Nebenwirkungen · Usgena
Usgena 130 mg concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 8
HOS-153947 · Präparat HOS-101078
Infections and infestations Common: Upper respiratory tract infection, nasopharyngitis, sinusitis Uncommon: Cellulitis, dental infections, herpes zoster, lower respiratory tract infection, viral upper respiratory tract infection, vulvovaginal mycotic infection Immune system disorders Uncommon: Hypersensitivity reactions (including rash, urticaria) Rare: Serious hypersensitivity reactions (including anaphylaxis, angioedema) Psychiatric disorders Uncommon: Depression Nervous system disorders Common: Dizziness, headache Uncommon: Facial palsy Respiratory, thoracic and Common: Oropharyngeal pain mediastinal disorders Uncommon: Nasal congestion Rare: Allergic alveolitis, eosinophilic pneumonia Very rare: Organising pneumonia* Gastrointestinal disorders Common: Diarrhoea, nausea, vomiting Skin and subcutaneous tissue Common: Pruritus disorders Uncommon: Pustular psoriasis, skin exfoliation, acne Rare: Exfoliative dermatitis, hypersensitivity vasculitis Very rare: Bullous pemphigoid, cutaneous lupus erythematosus Musculoskeletal and connective Common: Back pain, myalgia, arthralgia tissue disorders Very rare: Lupus-like syndrome
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-11T11:11:01Z · SHA-256 8e5be544de91a74438b6084c7497550446fa3104ba8f5e5368034aaef5a300fc · Passage d15986ba79c179842c9a66de6ee5295999e8c52c27c30409557acff6da4611f9 · Zeichen 2141–4148 im Abschnitt